Attractive Healthcare stock of Yesterday - Sucampo Pharmaceuticals, Inc. (SCMP)

Analysts await Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) or 15 shares. Ueno Ryuji sold $12.00 million worth of stock or 1.00 million shares. According to the latest data, the consensus recommendation for Sucampo Pharmaceuticals, Inc. Bank of New York Mellon Corp boosted its holdings in shares of Sucampo Pharmaceuticals by 13.0% in the 3rd quarter. They presently have a $18.00 price target on the biopharmaceutical company's stock. JPMorgan Chase & Co. purchased a new stake in shares of Sucampo Pharmaceuticals in the second quarter valued at $117,000. In the most recent quarterly financial report, for the quarter ending Sep. Finally, Aperio Group LLC bought a new stake in Sucampo Pharmaceuticals in the third quarter valued at about $137,000. (NASDAQ:SCMP). Federated Pa owns 424 shares. (NASDAQ:SCMP). New York State Teachers Retirement System has 0% invested in Sucampo Pharmaceuticals, Inc. At the same time as, it has debt to equity ratio of 0.00 and similar long term debt to equity ratio was 7.37. Finally, SGYP's beta of 1.24 indicates that the stock has an above average level of market risk. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) has declined 5.30% since January 9, 2017 and is downtrending.

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) gross margin percentage stands at 72.8% while its operating margin for the past trailing twelve month is -49.6 percent and its overall profit margin (ttm) is -60.2 Percent. They expect $-0.93 earnings per share, down 57.63% or $0.34 from last year's $-0.59 per share. For the past 5 years, the company's revenue has grown -14.7%, while the company's earnings per share has grown -51.2%.

Sucampo Pharmaceuticals, Inc. (SCMP) in the last quarter reported its actual EPS of $0.27/share where the analyst estimated EPS was $0.25/share.

Several research analysts recently weighed in on SCMP shares.

The 7 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 43.00 and a low estimate of 11.00. BidaskClub raised Sucampo Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Tuesday, December 5th. The stock price of SCMP is moving up from its 20 days moving average with 6.94% and isolated positively from 50 days moving average with 35.31%. Maxim Group restated a "buy" rating and issued a $23.00 price objective on shares of Sucampo Pharmaceuticals in a research report on Thursday, November 2nd.

Among 13 analysts covering Sucampo Pharma (NASDAQ:SCMP), 5 have Buy rating, 0 Sell and 8 Hold. The stock has a consensus rating of "Buy" and an average price target of $21.58.

In other news, insider Peter A. Kiener sold 50,000 shares of Sucampo Pharmaceuticals stock in a transaction dated Thursday, December 7th.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

WARNING: "Sucampo Pharmaceuticals (NASDAQ:SCMP) Downgraded by UBS Group to "Neutral" was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and global copyright and trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/13/sucampo-pharmaceuticals-scmp-stock-rating-reaffirmed-by-leerink-swann.html.

Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The Company is focused on the development and commercialization of pharmaceutical products.

Related Articles

  • Revenue Estimates Analysis Bank of America Corporation (BAC)

    BidaskClub cut shares of Bank of America from a "hold" rating to a "sell" rating in a research report on Tuesday, September 12th. The stock of Bank of America Corporation (NYSE:BAC) earned "Buy" rating by Keefe Bruyette & Woods on Tuesday, June 6.

    DISH Network (DISH) Rating Lowered to Sell at Zacks Investment Research

    DISH Network Corporation ( DISH ) has 0 billion shares outstanding now , 99.44% of which belong to institutional investors. Barclays Capital maintained DISH Network Corporation (NASDAQ: DISH ) on Friday, November 10 with "Overweight" rating.
    Hawaii officials say 'ballistic missile threat' emergency alert was mistake

    Hawaii officials say 'ballistic missile threat' emergency alert was mistake

    A voice over announced over the commentary that the incoming missile "was not a drill" and an impact could be "within minutes". President Donald Trump has been briefed on a false alert that Hawaii was under the threat of being hit by a ballistic missile.
  • Turnovers, poor rebounding hurt Aggies in loss to Tennessee, 75-62

    Turnovers, poor rebounding hurt Aggies in loss to Tennessee, 75-62

    Bowden led the Volunteers with 15 points while Alexander contributed 14 against Texas A&M's towering front line. After shooting 5 of 8 from beyond the arc in the first half, Texas A&M was just 3 of 12 in the second half.
    US President Trump waives Iran nuclear sanctions, however for final time

    US President Trump waives Iran nuclear sanctions, however for final time

    On Friday, Trump is set to decide whether to extend relief for Iran from some USA economic sanctions. Iran said on Saturday it would not accept any changes to its 2015 nuclear deal with world powers.
    Spurs will keep Kane and Alli this summer

    Spurs will keep Kane and Alli this summer

    The striker is the league top scorer with 20, three more than nearest rival Mohamed Salah. Levy also conceded that it is hard to get business done in the winter transfer window.
  • Willis Investment Counsel Purchases 7000 Shares of US Bancorp (USB)

    Willis Investment Counsel Purchases 7000 Shares of US Bancorp (USB)

    State Of Tennessee Treasury Department holds 30,064 shares or 0.01% of its portfolio. 53,375 were reported by Agf Invests America. Prudential Financial Inc, New Jersey-based fund reported 227,583 shares. 36,217 were accumulated by Ubs Asset Mgmt Americas.
    David Harbour Crashed Someone's Yearbook Photos, Just Like He Promised

    David Harbour Crashed Someone's Yearbook Photos, Just Like He Promised

    While, Twitter users went insane and over Harbour's reponse, his co-star Noah Schapp even joined in on the fun and supported the cause.
    West Virginia vs Texas Tech basketball

    West Virginia vs Texas Tech basketball

    Senior Niem Stevenson is from Dallas and starts at the two, he averages eight points per game this year in just over 20 minutes. Five players are averaging at least 9.1 points per game for West Virginia , they are: Jevon Carter (16.1), Daxter Miles Jr .
  • "How To Kill Someone" Internet Search Helps Police Arrest Texas Wife

    According to the publication, officers found Jon Garner dead on January 2 inside the home he and his 55-year-old wife shared. Norton told eParisExtra at the time: "There were rumors this was a random home invasion".
    Fire at airport before Prez Ram Nath Kovind visit

    Fire at airport before Prez Ram Nath Kovind visit

    The blaze, which has been doused as of publishing this report, did not lead to any casualties or affect operations in any way. The fire was doused at 3.18 pm; President Kovind passed through the gate at 3.30 pm.
    Trump extends Iran sanctions relief, warns it's the last time

    Trump extends Iran sanctions relief, warns it's the last time

    The White House wants European Union signatories to agree permanent restrictions on Iran's uranium enrichment. The department has linked Larijani to "the commission of serious human rights abuses" against Iranian people.